202 related articles for article (PubMed ID: 17466519)
1. Optimization of triaryl bis-sulfones as cannabinoid-2 receptor ligands.
Lavey BJ; Kozlowski JA; Shankar BB; Spitler JM; Zhou G; Yang DY; Shu Y; Wong MK; Wong SC; Shih NY; Wu J; McCombie SW; Rizvi R; Wolin RL; Lunn CA
Bioorg Med Chem Lett; 2007 Jul; 17(13):3760-4. PubMed ID: 17466519
[TBL] [Abstract][Full Text] [Related]
2. Expansion of SAR studies on triaryl bis sulfone cannabinoid CB2 receptor ligands.
Tong L; Shankar BB; Chen L; Rizvi R; Kelly J; Gilbert E; Huang C; Yang DY; Kozlowski JA; Shih NY; Gonsiorek W; Hipkin RW; Malikzay A; Lunn CA; Lundell DJ
Bioorg Med Chem Lett; 2010 Nov; 20(22):6785-9. PubMed ID: 20850969
[TBL] [Abstract][Full Text] [Related]
3. Triaryl bis-sulfones as cannabinoid-2 receptor ligands: SAR studies.
Shankar BB; Lavey BJ; Zhou G; Spitler JA; Tong L; Rizvi R; Yang DY; Wolin R; Kozlowski JA; Shih NY; Wu J; Hipkin RW; Gonsiorek W; Lunn CA
Bioorg Med Chem Lett; 2005 Oct; 15(20):4417-20. PubMed ID: 16115769
[TBL] [Abstract][Full Text] [Related]
4. Novel benzimidazole derivatives as selective CB2 agonists.
Pagé D; Balaux E; Boisvert L; Liu Z; Milburn C; Tremblay M; Wei Z; Woo S; Luo X; Cheng YX; Yang H; Srivastava S; Zhou F; Brown W; Tomaszewski M; Walpole C; Hodzic L; St-Onge S; Godbout C; Salois D; Payza K
Bioorg Med Chem Lett; 2008 Jul; 18(13):3695-700. PubMed ID: 18522867
[TBL] [Abstract][Full Text] [Related]
5. Triaryl bis-sulfones as a new class of cannabinoid CB2 receptor inhibitors: identification of a lead and initial SAR studies.
Lavey BJ; Kozlowski JA; Hipkin RW; Gonsiorek W; Lundell DJ; Piwinski JJ; Narula S; Lunn CA
Bioorg Med Chem Lett; 2005 Feb; 15(3):783-6. PubMed ID: 15664857
[TBL] [Abstract][Full Text] [Related]
6. Non-aromatic A-ring replacement in the triaryl bis-sulfone CB2 receptor inhibitors.
Gilbert EJ; Zhou G; Wong MK; Tong L; Shankar BB; Huang C; Kelly J; Lavey BJ; McCombie SW; Chen L; Rizvi R; Dong Y; Shu Y; Kozlowski JA; Shih NY; Hipkin RW; Gonsiorek W; Malikzay A; Lunn CA; Favreau L; Lundell DJ
Bioorg Med Chem Lett; 2010 Jan; 20(2):608-11. PubMed ID: 20005710
[TBL] [Abstract][Full Text] [Related]
7. Rapid assessment of a novel series of selective CB(2) agonists using parallel synthesis protocols: A Lipophilic Efficiency (LipE) analysis.
Ryckmans T; Edwards MP; Horne VA; Correia AM; Owen DR; Thompson LR; Tran I; Tutt MF; Young T
Bioorg Med Chem Lett; 2009 Aug; 19(15):4406-9. PubMed ID: 19500981
[TBL] [Abstract][Full Text] [Related]
8. 1,2,3-Triazole derivatives as new cannabinoid CB1 receptor antagonists.
Hou DR; Alam S; Kuan TC; Ramanathan M; Lin TP; Hung MS
Bioorg Med Chem Lett; 2009 Feb; 19(3):1022-5. PubMed ID: 19095444
[TBL] [Abstract][Full Text] [Related]
9. New QSAR prediction models derived from GPCR CB2-antagonistic triaryl bis-sulfone analogues by a combined molecular morphological and pharmacophoric approach.
Chen JZ; Myint KZ; Xie XQ
SAR QSAR Environ Res; 2011; 22(5-6):525-44. PubMed ID: 21714749
[TBL] [Abstract][Full Text] [Related]
10. Pyridopyrimidine based cannabinoid-1 receptor inverse agonists: Synthesis and biological evaluation.
Debenham JS; Madsen-Duggan CB; Wang J; Tong X; Lao J; Fong TM; Schaeffer MT; Xiao JC; Huang CC; Shen CP; Sloan Stribling D; Shearman LP; Strack AM; Euan Macintyre D; Hale JJ; Walsh TF
Bioorg Med Chem Lett; 2009 May; 19(9):2591-4. PubMed ID: 19328684
[TBL] [Abstract][Full Text] [Related]
11. Morpholine containing CB2 selective agonists.
Zindell R; Riether D; Bosanac T; Berry A; Gemkow MJ; Ebneth A; Löbbe S; Raymond EL; Thome D; Shih DT; Thomson D
Bioorg Med Chem Lett; 2009 Mar; 19(6):1604-9. PubMed ID: 19243942
[TBL] [Abstract][Full Text] [Related]
12. 2-Arylimino-5,6-dihydro-4H-1,3-thiazines as a new class of cannabinoid receptor agonists. Part 3: Synthesis and activity of isosteric analogs.
Kai H; Morioka Y; Koriyama Y; Okamoto K; Hasegawa Y; Hattori M; Koike K; Chiba H; Shinohara S; Iwamoto Y; Takahashi K; Tanimoto N
Bioorg Med Chem Lett; 2008 Dec; 18(24):6444-7. PubMed ID: 18977140
[TBL] [Abstract][Full Text] [Related]
13. Novel pyridine derivatives as potent and selective CB2 cannabinoid receptor agonists.
Chu GH; Saeui CT; Worm K; Weaver DG; Goodman AJ; Broadrup RL; Cassel JA; DeHaven RN; LaBuda CJ; Koblish M; Brogdon B; Smith S; Le Bourdonnec B; Dolle RE
Bioorg Med Chem Lett; 2009 Oct; 19(20):5931-5. PubMed ID: 19736007
[TBL] [Abstract][Full Text] [Related]
14. Sulfamoyl benzamides as novel CB2 cannabinoid receptor ligands.
Worm K; Zhou QJ; Saeui CT; Green RC; Cassel JA; Stabley GJ; DeHaven RN; Conway-James N; LaBuda CJ; Koblish M; Little PJ; Dolle RE
Bioorg Med Chem Lett; 2008 May; 18(9):2830-5. PubMed ID: 18430570
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological evaluation of piperazine analogues as CB1 cannabinoid receptor ligands.
Song KS; Lee SH; Chun HJ; Kim JY; Jung ME; Ahn K; Kim SU; Kim J; Lee J
Bioorg Med Chem; 2008 Apr; 16(7):4035-51. PubMed ID: 18243711
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of novel tri-aryl CB2 selective cannabinoid ligands.
Bhattacharjee H; Gurley SN; Moore BM
Bioorg Med Chem Lett; 2009 Mar; 19(6):1691-3. PubMed ID: 19230659
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of a novel series of N-alkyl isatin acylhydrazone derivatives that act as selective cannabinoid receptor 2 agonists for the treatment of neuropathic pain.
Diaz P; Xu J; Astruc-Diaz F; Pan HM; Brown DL; Naguib M
J Med Chem; 2008 Aug; 51(16):4932-47. PubMed ID: 18666769
[TBL] [Abstract][Full Text] [Related]
18. Lead optimization of 5,6-diarylpyridines as CB1 receptor inverse agonists.
Madsen-Duggan CB; Debenham JS; Walsh TF; Toupence RB; Huang SX; Wang J; Tong X; Lao J; Fong TM; Schaeffer MT; Xiao JC; Huang CR; Shen CP; Stribling DS; Shearman LP; Strack AM; MacIntyre DE; Van der Ploeg LH; Goulet MT
Bioorg Med Chem Lett; 2007 Apr; 17(7):2031-5. PubMed ID: 17270441
[TBL] [Abstract][Full Text] [Related]
19. Indol-3-yl-tetramethylcyclopropyl ketones: effects of indole ring substitution on CB2 cannabinoid receptor activity.
Frost JM; Dart MJ; Tietje KR; Garrison TR; Grayson GK; Daza AV; El-Kouhen OF; Miller LN; Li L; Yao BB; Hsieh GC; Pai M; Zhu CZ; Chandran P; Meyer MD
J Med Chem; 2008 Mar; 51(6):1904-12. PubMed ID: 18311894
[TBL] [Abstract][Full Text] [Related]
20. 2,5-Disubstituted pyridines: the discovery of a novel series of 5-HT2A ligands.
Wilson KJ; van Niel MB; Cooper L; Bloomfield D; O'Connor D; Fish LR; MacLeod AM
Bioorg Med Chem Lett; 2007 May; 17(9):2643-8. PubMed ID: 17314044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
